CDKN2A and prostate cancer: Yap et al. found that lncRNA ANRIL was significantly up-regulated in prostate cancer and involved in repressing of the p15/CDKN2B-p16/CDKN2Ap14/ARF gene cluster in Cis by directly binding to the PRC [16].